Related Experiment Videos
Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation
A Vayá1, M J Forner, A Estellés
1Thrombosis and Hemostasis Unit, Dept. of Clinical Pathology, La Fe University Hospital, Avda. Campanar 21, 46009 Valencia, Spain.
Insights
Behçet's disease patients have a higher risk of thrombosis. A rare case links Behçet's disease with a prothrombin gene mutation, potentially explaining intracardiac thrombosis in this patient.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Rheumatology
Background:
- Behçet's disease (BD) is a multisystem vasculitis associated with a 20-30% risk of thrombosis.
- The exact mechanisms driving thrombotic events in BD remain unclear.
- Intracardiac thrombi are exceptionally rare manifestations of venous thrombosis in BD.
Observation:
- This report details an unusual case of a young patient diagnosed with Behçet's disease.
- The patient presented with a rare right intracardiac thrombus.
- Genetic analysis revealed the presence of the 20210G-A prothrombin gene mutation.
Findings:
- The co-occurrence of Behçet's disease and the 20210G-A prothrombin gene mutation was identified.
- This specific genetic mutation is a known prothrombotic factor.
- The combination of BD and this mutation is hypothesized to contribute to thrombotic events.
Implications:
- This case highlights a potential genetic predisposition for thrombosis in certain Behçet's disease patients.
- The 20210G-A prothrombin gene mutation may play a significant role in the pathogenesis of rare thrombotic events in BD.
- Further research into genetic factors in BD-associated thrombosis is warranted.
Abstract:
Thrombosis occurs in 20 to 30% of patients with Behçet's disease (BD), but the precise pathogenic mechanism underlying the thrombotic tendency in these patients is not well known. Venous thromboses are commonly located in the lower extremities, but right intracardiac thrombi are extremely rare. We report for the first time on a young patient with BD associated the 20210G-A prothrombin gene mutation and right intracardiac thrombosis. We suggest that the association of BD with this newly recognized prothrombotic genetic mutation may have contributed to the development of the thrombotic event in this patient.